title: Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.
abstract: In a study on the effects of smoked cannabis (18.2 +/- 2.8 mg as low and 36.5 +/- 5.6 mg as high dose) paired blood and oral fluid samples were collected from 10 study participants up to 6 h after smoking and analyzed for the cannabinoids Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC (THC-OH) and 11-nor-9-carboxy-THC (THCA) using gas chromatography-mass spectrometry. Highest concentrations in serum were 47.8 +/- 35.0 and 79.1 +/- 42.5 microg/L at the end of smoking (low and high dose, respectively) and decreased to less than 1 microg/L during 6 h with elimination half-lives of 1.4 +/- 0.1 h calculated from 1 to 6 h, which is shorter than reported previously. The elimination half-lives of THC-OH (2.0 +/- 0.3 h) and THCA (3.4 +/- 0.9 h) were significantly higher. The THC concentrations in oral fluid were highest with 900 +/- 589 and 1041 +/- 652 microg/L (low and high dose, respectively) in the first sample collected at 0.25 h and decreased to 18 +/- 12 microg/L over 6 h with elimination half-lives of 1.5 +/- 0.6 h. The elimination half-life of THC in serum and oral fluid and between the two doses did not significantly differ. Oral fluid/serum ratios were 46 +/- 27 and 36 +/- 20 (low and high dose, respectively), which are higher than previously reported and might be based on sample collection and/or analytical issues. In conclusion, despite similar elimination rates of THC in serum and oral fluid, which appear incidental, the high differences in oral fluid/serum ratios are not a reliable basis for correlating THC concentrations in oral fluid and serum. The oral compartment and its kinetics for drugs, particularly THC, are not yet satisfactorily understood.
authors.affiliation: Institute of Forensic Toxicology, University of Frankfurt, Frankfurt, Main, Germany.
authors.forename: Gerold F
authors.initials: GF
authors.lastname: Kauert
authors.forename: Johannes G
authors.initials: JG
authors.lastname: Ramaekers
authors.forename: Erhard
authors.initials: E
authors.lastname: Schneider
authors.forename: Manfred R
authors.initials: MR
authors.lastname: Moeller
authors.forename: Stefan W
authors.initials: SW
authors.lastname: Toennes
mesh_terms: D000328:Adult; D002186:Cannabinoids / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D013759:Dronabinol / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006207:Half-Life; D006801:Humans; D008297:Male; D008385:Marijuana Smoking / Q000097:blood / Q000378:metabolism; D012015:Reference Standards; D012463:Saliva / Q000737:chemistry*; D044967:Serum; D015813:Substance Abuse Detection
chemical_list: D002186:Cannabinoids; D013759:Dronabinol